Categories
| Category | |
|---|---|
| Biotechnology and Pharmaceuticals | 85% |
| Health | 15% |
Explore sites in same category:
- kenkoulife.club Rank 4.3M. Estimated value 492$
- appliedclinicaltrialsonline.com Rank 707.2K. Estimated value 3,048$
- trialscope.com Rank 794.2K. Estimated value 2,712$
- nisshin-pharma.com Rank 270.5K. Estimated value 8,040$
- wuxuwang.com Rank 131.8K. Estimated value 16,596$
- tofflon.com Rank 3.3M. Estimated value 648$
- akp-pharma-digital.com Rank 1.3M. Estimated value 1,668$
- aisyukai.com Rank 2.1M. Estimated value 1,032$
- oki-hifuka.com Rank 4.4M. Estimated value 480$
- karakoto.com Rank 160.4K. Estimated value 13,620$
Keyword Suggestion
Domain Informations
Astrazeneca.com lookup results from whois.comlaude.com server:
- Domain created: 1998-12-08T05:00:00Z
- Domain updated: 2024-04-08T18:49:01Z
- Domain expires: 2025-12-07T05:00:00Z 1 Year, 234 Days left
- Website age: 25 Years, 130 Days
- Registrar Domain ID: 4286791_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- DNS1.COMLAUDE-DNS.COM
- DNS2.COMLAUDE-DNS.NET
- DNS3.COMLAUDE-DNS.CO.UK
- DNS4.COMLAUDE-DNS.EU
Network
- inetnum : 15.196.0.0 - 15.200.255.255
- name : AT-88-Z
- handle : NET-15-196-0-0-1
- status : Direct Allocation
- created : 2011-12-08
- changed : 2024-01-24
- desc : -----BEGIN CERTIFICATE-----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-----END CERTIFICATE-----,All abuse reports MUST include:,* src IP,* dest IP (your IP),* dest port,* Accurate date/timestamp and timezone of activity,* Intensity/frequency (short log extracts),* Your contact details (phone and email) Without these we will be unable to identify the correct owner of the IP address at that point in time.
Owner
- organization : Amazon Technologies Inc.
- handle : AT-88-Z
- address : Array,Seattle,WA,98109,US
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 15.197.255.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 15.197.255.153)
Spam Check (IP: 15.197.255.153)
Email address with astrazeneca.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
8. [email protected]
Websites Listing
We found Websites Listing below when search with astrazeneca.com on Search Engine
Contact Us - AstraZeneca
Email: [email protected] . Monday - Friday 8 a.m. - 5 p.m. (EST), excluding holidays. Information from your request will be documented within our AstraZeneca database. AstraZeneca Canada is committed to protect and control the collection, use and disclosure of personal information of individuals that interact with us in accordance with applicable …
Astrazeneca.caContact Us - Our Company - AstraZeneca
If you are in the United States and would like additional information regarding AstraZeneca products, or you are a third party with an offer of services for AstraZeneca, you can contact the AstraZeneca Information Center by phone at 1-800-236-9933 (Monday-Friday, 8am-8pm ET, excluding holidays). Outside these hours and on holidays, an Afterhours service is available to …
Astrazeneca.comAstra Zeneca email format | AstraZeneca.com emails
13 rows · AstraZeneca uses 7 email formats, with (firstname). (lastname) (ex. …
Aeroleads.comAstraZeneca Canada
AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing. Visit the COVID-19 Information Hub for more information. Science compels us to push the boundaries of what is possible. We trust in the potential of ideas and pursue them, alone and with others, until we …
Astrazeneca.caAstrazeneca Email Login Find Your Account (by Email or ...
This website is available to AstraZeneca employees and accredited partner organisations. It’s easy to register. Simply follow the three steps below to create your profile and gain access to a wealth of information about GDD. Click on the Register button below. Enter your email address and click submit. You will receive a verification email.
Setlog.netlify.appContact Us - AstraZeneca US
For media inquiries, please contact us via the US Media Line at 1-302-885-2677 or by email at [email protected]. Investor Inquiries. Visit our Investor relations page. North America Commercial Headquarters. 1800 Concord Pike Wilmington, DE 19850 800-456-3669. Gaithersburg Location. 1 MedImmune Way Gaithersburg, Maryland 20878 301-398-0000. …
Astrazeneca-us.comFrequently asked questions - AstraZeneca
Please note - In recent weeks there has been an increase in suspicious email activity from people masquerading as recruiters for AstraZeneca. These have been using very realistic looking material, imitating AstraZeneca people, involving fake offers of employment and asking for the exchange of money and credit card details. AstraZeneca will never ask for money at any point …
Careers.astrazeneca.comWorking at AstraZeneca
Life at AstraZeneca. We’re curious about science and the advancement of knowledge. We find creative ways to approach new challenges. We’re driven to make the right choices and be accountable for our actions. As an organisation centred around what makes us human, we put a big focus on people. Across our business, we want colleagues to wake up excited about their …
Careers.astrazeneca.comUS Court Revives Lawsuit Against Pfizer, AstraZeneca ...
2 hours ago · A US appeals court on Tuesday revived a lawsuit against AstraZeneca, Pfizer and other companies over allegations their contracts with …
Ndtv.comAstraZeneca and Ovid Therapeutics Team Up Against Epilepsy ...
1 day ago · AstraZeneca also stands to gain up to $8 million in clinical development milestones and up to $45 million in regulatory milestones. OV350 is an early-stage compound that has demonstrated strong proofs of concept in in-vivo and in-vitro types of epilepsy. It is designed to target and activate KCC2, a potassium chloride co-transporter credited for maintaining chloride …
Biospace.comAstraZeneca COVID-19 vaccine significantly boosted ...
2 days ago · AstraZeneca’s COVID-19 vaccine (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529 Monday, 03 January 2022 11:52 GMT عربي
Menafn.comAstraZeneca says it is working on an Omicron vaccine with ...
2021-12-22 · AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant ...
Globalnews.caPfizer Or AstraZeneca Booster For AstraZeneca Vaccine ...
2021-11-25 · An AstraZeneca booster will only be given if recipients cannot have Pfizer or Moderna. In South Korea, where SK Bioscience produces Covid-19 vaccines for AstraZeneca, the Korea Disease Control and Prevention Agency (KDCA) also recommends booster vaccinations with an mRNA vaccine made by Pfizer or Moderna for AstraZeneca recipients. …
Codeblue.galencentre.orgOmicron variant: AstraZeneca exploring impact on vaccine ...
2021-11-26 · AstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.
Globalnews.caAstraZeneca vaccine booster works against Omicron, Oxford ...
2021-12-23 · The study on AstraZeneca’s vaccine, Vaxzevria, showed that after a three-dose course of the vaccine, neutralizing levels against Omicron were broadly similar to those against the virus’s Delta variant after two doses. The London-listed company said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine …
Financialpost.comFDA clears AstraZeneca Covid antibody treatment for ...
2021-12-10 · The FDA issued an emergency use authorization Wednesday for AstraZeneca’s antibody cocktail, Evusheld, for what is known as pre-exposure prophylaxis, or PrEP, against Covid-19. To date, such ...
Cnbc.comB.C. residents who got 2 AstraZeneca doses may get booster ...
2021-11-01 · B.C. residents who received two AstraZeneca shots to protect themselves against COVID-19 may receive an invitation to get their booster shot a little earlier than others.
Bc.ctvnews.caAstraZeneca therapy works against Omicron; results mixed ...
2021-12-16 · AstraZeneca and Regeneron on Thursday reported contrasting data on the effectiveness of their COVID-19 antibody therapies against the Omicron variant of the coronavirus, underscoring the major ...
Torontosun.comOver 8.6m AstraZeneca doses received
2021-12-24 · LAHORE: AstraZeneca has delivered over 8.6million doses of Covid-19 Vaccine AstraZeneca ) to Pakistan during 2021 to help boost the vaccination programme. These doses were supplied to Pakistan via...
Thenews.com.pkAstraZeneca, Oxford aim to produce Omicron-targeted ...
2021-12-22 · AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant ...
Newsinfo.inquirer.net
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| helloyoudating.com | srsplus.com | -2 Years, -29 Days |
| jscounter.com | namecheap.com | -1 Years, -297 Days |
| css3menu.com | godaddy.com | 1 Year, 334 Days |
| sobelathome.com | godaddy.com | 3 Years, 12 Days |
| gracefulorganix.com | name.com | -1 Years, -90 Days |
| friargatepreston.com | netistrar.com | -1 Years, -128 Days |
| drcrooker.com | godaddy.com | -1 Years, -322 Days |
| krebsautodetailing.com | domains.google.com | -2 Years, -30 Days |
| exudehc.com | godaddy.com | -1 Years, -10 Days |
| loyalcougars.com | domains.google.com | -1 Years, -332 Days |